Editorial & Opinion

Beyond survival: addressing sexual health in advanced prostate cancer care.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Beyond survival: addressing sexual health in advanced prostate cancer care.
Συγγραφείς: De Rose AF; Villa Montallegro Private Hospital, Genoa., Ciuffarella S; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa., Gallo F; Department of Urology, San Paolo Hospital, Savona., Mantica G; Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genoa.
Πηγή: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2026 Sep 25; Vol. 98 (3), pp. 15702. Date of Electronic Publication: 2026 Jul 29.
Τύπος έκδοσης: Letter
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: PagePress Country of Publication: Italy NLM ID: 9308247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2282-4197 (Electronic) Linking ISSN: 11243562 NLM ISO Abbreviation: Arch Ital Urol Androl Subsets: MEDLINE
Imprint Name(s): Publication: Pavia, Italy : PagePress
Original Publication: Milano : Masson, c1993-
Ιατρικοί όροι (MeSH): Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/diagnosis , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/mortality , Sexual Health* , Quality of Life*, Humans ; Male ; Survival Rate ; Italy
Περίληψη: Dear Editor, The therapeutic landscape of prostate cancer (PCa) has changed considerably over the last decade, with clear improvements in diagnosis, including PSMA PET and fusion biopsies, treatment options, and survival. Consequently, a growing number of patients are now living longer after their PCa initial diagnosis, and increasing attention is progressively shifting toward long-term quality of life. In Italy, men living after a diagnosis of prostate cancer increased from 217,000 in 2014 to 485,000 in 2024, with a five-year survival rate of approximately 91% [...].
References: 1. De Nunzio C, Lombardo R, Baldassarri V, et al. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter.
external validation. Eur J Surg Oncol. 2021; 47 :2640-2645.
2. Bauckneht M, Rebuzzi SE, Ponzano M, et al. Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients.
Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Cancers (Basel). 2022; 14:1744.
3. Mantica G, Pacchetti A, Aimar R, et al. Developing a five-step training model for transperineal prostate biopsies in a naïve residents' group:.
a prospective observational randomised study of two different techniques. World J Urol. 2019; 37:1845-1850.
4. Brant A, Campi R, Carrion DM, et al. Findings from an international survey of urology trainee experience with prostate biopsy. BJU Int. 2023;.
131:705-711.
5. MacLennan S, Azevedo N, Duncan E, et al. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of.
Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. Eur Urol.
2023; 83:393-401.
6. De Marchi D, Mantica G, Tafuri A, Giusti G, Gaboardi F. Robotic surgery in urology: a review from the beginning to the single-site. AME Med.
J 2022; 7:16.
7. Hyun JS. Sexual function in men with prostate cancer. World J Mens Health. 2012; 30:99-107.
8. AIOM, AIRTUM, Fondazione AIOM, PASSI, PASSI d’Argento, SIAPeC-IAP. I numeri del cancro in Italia 2024. Milano: Associazione Italiana.
di Oncologia Medica; 2024. Available from: AIOM official report.
9. Mainwaring JM, Walker LM, Robinson JW, Wassersug RJ, Wibowo E. The psychosocial consequences of prostate cancer treatments on body.
image, sexuality, and relationships. Front Psychol. 2021; 12:765315.
10. Paterson CL, Lengacher CA, Donovan KA, Kip KE, Tofthagen CS. Body image in younger breast cancer survivors: a systematic review.
Cancer Nurs. 2016; 39:E39-E58.
11. Zambudio-Munuera A, Millán-Ramos I, Rodríguez-Parras P, et al. Early risk stratification after robot-assisted radical prostatectomy: the role.
of positive surgical margins. Arch Ital Urol Androl. 2026; 98:14871.
12. Nicolai M, Urkmez A, Sarikaya S, Fode M. Penile Rehabilitation and Treatment Options for Erectile Dysfunction Following Radical.
Prostatectomy and Radiotherapy: A Systematic Review. Front Surg. 2021; 8:636974.
13. Donovan KA, Walker LM, Wassersug RJ, et al. The impact of androgen deprivation therapy on sexual function and bother in men with.
prostate cancer. J Sex Med. 2017.
14. Mazzola CR, Mulhall JP. Impact of androgen deprivation therapy on sexual function. Asian J Androl. 2012; 14:198-203.
15. De Rose AF, Gallo F, Mantica G, et al. Comparison of intraoperative and postoperative results after tricomponent penile prosthesis implantation.
under spinal versus local anaesthesia. Arch Ital Urol Androl. 2026.
Contributed Indexing: Keywords: Prostate cancer; cancer survivorship; sexual health
Entry Date(s): Date Created: 20260819 Date Completed: 20260928 Latest Revision: 20260929
Update Code: 20260929
DOI: 10.4081/aiua.2026.15702
PMID: 42613994
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:2282-4197
DOI:10.4081/aiua.2026.15702